Institutional members access full text with Ovid®

Understanding the Financial Impact of Robotics in Gynecologic Surgery

SWAN, KIMBERLY MD*; ADVINCULA, ARNOLD P. MD

Clinical Obstetrics & Gynecology: September 2011 - Volume 54 - Issue 3 - p 449–457
doi: 10.1097/GRF.0b013e31822ce22c
Robotic Surgery in Gynecology

As surgical innovation and technological advancements evolve, the associated costs cannot be overlooked. Currently, the United States health care system is undergoing an attempted overhaul with technology such as robotics sitting front and center of the financial debate. As patient demand for less invasive surgical options increases and standards of practice change, patient outcomes must be carefully evaluated to justify the costs increase from traditional, often more invasive treatments. The collection of financial data is quite varied among hospital systems and so is the models used to determine the costs of robotics. Although limited thus far, various cost data have been ascertained in the areas of reproductive surgery, hysterectomy (both benign and oncologic), and pelvic reconstructive surgery.

*Minimally Invasive Gynecologic Surgery;

Department of Obstetrics and Gynecology, University of Central Florida College of Medicine, Florida Hospital Celebration Health, Celebration, Florida

Dr Advincula serves as a Consultant: Intuitive Surgical, Cooper Surgical, Covidien, Genzyme, Ethicon Women's Health and Urology.Dr Swan has nothing to disclose.

Correspondence: Arnold P. Advincula, MD, Department of Obstetrics and Gynecology, University of Central Florida College of Medicine, Florida Hospital Celebration Health, 410 Celebration Place, Suite 302, Celebration, FL 34747. E-mail: arnold.advincula.md@flhosp.org

© 2011 Lippincott Williams & Wilkins, Inc.